Work With Us
Contact Us
Work With Us
Contact Us
Search
Search
Close this search box.
Home
About Us
Our Mission and Vision
Meet the Team
Board of Directors
Scientific Advisory Board
Investors
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Publications
What’s New
Press Releases
Events
Menu
Home
About Us
Our Mission and Vision
Meet the Team
Board of Directors
Scientific Advisory Board
Investors
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Publications
What’s New
Press Releases
Events
Press
Releases
News
Latest
press releases
Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors
July 1, 2024
Press Releases
Compelling Data in Breast Cancer Treatment with First-In-Class Cyclin A/B Inhibitor Presented at 2023 AACR-NCI-EORTC International Conference
October 23, 2023
Press Releases
Circle Pharma Announces Upcoming Presentation at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 9, 2023
Press Releases
Circle Pharma strengthens its executive leadership team with two senior appointments in Clinical Development
July 26, 2023
Press Releases
Circle Pharma Achieves Major Milestone with the Selection of a Clinical Development Candidate Directly Inhibiting Cyclins A and B
July 19, 2023
Press Releases
Circle Pharma’s first-in-class orally bioavailable macrocyclic cyclin A/B inhibitors highlighted in poster presentations at American Association for Cancer Research Annual Meeting
April 19, 2023
Press Releases
LOAD MORE
Sign up to stay informed
SUBSCRIBE
Subscribe to our News Alerts
By checking the box and pressing the subscribe button , I acknowledge and accept Circle Pharma’s
Privacy Policy
and
Terms of Service.
Subscribe
